Achilles Therapeutics prices its ADS at an IPO rate of $18
LONDON: Syncona Ltd’s portfolio company Achilles Therapeutics plc has announced the pricing of its initial public offering (IPO) in the United States of 9.75 million...
Piedmont Lithium plans U.S. public offering of American Depositary Shares
SYDNEY: Piedmont Lithium Limited plans to conduct a U.S. public offering of up to 1.5 million of its American Depositary Shares (ADSs), with each ADS...
IDEX Biometrics ADSs to be Listed on Nasdaq as of 1 March
OSLO: IDEX Biometrics ASA announced that the Company will list American Depositary Shares (ADSs) each representing 75 ordinary shares of the Company on the Nasdaq...